Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thyroid stimulating hormone measurement
|
83 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.800 | 1.000 | 1 | 2013 | 2013 | ||||||
Alkaline phosphatase measurement
|
79 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.700 | 1.000 | 2 | 2008 | 2013 | ||||||
Venous Thromboembolism
|
408 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.700 | 1.000 | 2 | 2011 | 2012 | ||||||
Activated Partial Thromboplastin Time measurement
|
44 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||
Autoantibody measurement
|
52 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||
C-reactive protein measurement
|
624 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||
Duodenal Ulcer
|
33 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
Finding of liver enzyme levels
|
10 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.700 | 1.000 | 1 | 2008 | 2008 | ||||||
Hormone measurement
|
134 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||
Measurement of liver enzyme
|
10 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.700 | 1.000 | 1 | 2008 | 2008 | ||||||
Polysomnography
|
249 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
Protein measurement
|
422 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
Pseudocholinesterase Measurement
|
568 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||
Serum albumin measurement
|
3282 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||
Serum total cholesterol measurement
|
1243 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
Soluble Interleukin 6 Receptor Measurement
|
25 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
Venous Thrombosis
|
218 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
von Willebrand's factor (lab test)
|
427 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||
Coronary Artery Disease
|
1577 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
Malignant Neoplasms
|
1641 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Primary malignant neoplasm
|
1374 | 0.882 | 0.200 | 9 | 133263862 | intron variant | A/C;T | snv | 0.010 | 1.000 | 1 | 2014 | 2014 |